GCGiuseppe Craparo

Giuseppe Craparo

*This is an algorithmically generated author record based on publicly available information.

Giuseppe Craparo has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improving Risk Stratification and Surgical Decision-Making for Unruptured Cerebral Aneurysm: A Proof-of-Concept of Novel Morphological Parameters and Computational Hemodynamics

    by Giuseppe Roberto Giammalva, Gabriele Costantino, Umberto Emanuele Benigno, Lapo Bonosi, Micol Tantillo, Antonino Cirello, Vito Ricotta, Tommaso Ingrassia, Giuseppe Craparo, Giovanni Tringali

    Background: Unruptured intracranial aneurysms (UIAs) represent a major challenge in neurosurgical practice. Rupture risk assessment traditionally relies on qualitative parameters, such as aneurysm size and shape, combined with surgical judgment and clinical expertise. However, these approaches may fail to account for the complex interplay between vascular morphology and hemodynamic forces that leads to aneurysm growth and rupture. Therefore, the development of reliable and quantitative parameters is essential to support neurosurgeons in balancing the risks of intervention against the natural history of the disease, thus optimizing decision-making for surgery. Methods: We developed an integrative framework based on a novel morphological parameter (MP), integrating multiple geometric descriptors into a single quantifiable index. To complement morphological assessment, patient-specific computational fluid dynamics (CFD) simulations were performed to evaluate hemodynamic factors known to influence aneurysm progression, thus analyzing structural and flow-related determinants of rupture risk. Results: In a cohort of 60 consecutive patients with MCA UIAs, MP showed strong concordance with the treatment decision made by an expert neurosurgeon regarding the indication for surgical clipping of aneurysms considered at risk of imminent rupture, providing an indirect, objective measure of UIA rupture risk stratification. CFD analyses confirmed that adverse hemodynamic conditions, including elevated intra-aneurysmal pressures and heterogeneous distribution of wall shear stress, correlated with unfavorable morphological features that were considered to indicate a higher risk of rupture by an expert neurosurgeon. Moreover, the integration of expert clinical judgment with quantitative indices may enhance the discrimination between aneurysms requiring early surgical intervention and those suitable for conservative management. Conclusions: This proof-of-concept study highlights the potential added value of combining morphological modelling and patient-specific hemodynamic analysis to support, rather than replace, expert neurosurgical judgment regarding the surgical management of unruptured MCA aneurysms. The proposed parameter (MP) shows concordance with expert operability decisions and may complement current neurosurgical evaluation as an ancillary decision-support tool, potentially contributing to safer operative strategies, more individualized patient management, and ultimately improved patient outcomes in the treatment of unruptured intracranial aneurysms.

  • Open Access

    Development of a morphological parameter and hemodynamic analysis to assess aneurysm operability

    by Micol Tantillo, Giuseppe Craparo, Antonino Cirello, Gabriele Costantino, Arezia Di Martino, Tommaso Ingrassia, Giuseppe Vincenzo Marannano, Agostino Igor Mirulla, Giovanni Tringali, Vito Ricotta

    Cerebral aneurysm is a complex vascular pathology, and the assessment of its rupture risk is often based on qualitative criteria and clinical expertise. The present study aims to develop an objective parameter to support risk evaluation by integrating morphological and hemodynamic analyses. A novel morphological parameter has been introduced, combining key geometric features extracted from 3D vessel reconstructions of middle cerebral artery bifurcations. Computational fluid dynamics (CFD) simulations were conducted to analyze hemodynamic factors such as wall shear stress and intra-aneurysmal pressure, both of which are associated with aneurysm growth and rupture risk. Particular attention was given to defining physiologically accurate boundary conditions, essential for obtaining reliable results. The new morphological parameter alignment with clinical evaluations suggesting its potential to enhance the assessment of aneurysm operability and improve surgical decision-making. This study highlights the importance of integrating morphological and hemodynamic data into the risk assessment process to refine risk stratification and guide more effective treatment strategies. Graphical Abstract


  • Open Access

    Preferred Imaging for Target Volume Delineation for Radiotherapy of Recurrent Glioblastoma: A Literature Review of the Available Evidence

    by Francesco Cuccia, Fatemeh Jafari, Salvatore D’alessandro, Giuseppe Carruba, Giuseppe Craparo, Giovanni Tringali, Livio Blasi, Giuseppe Ferrera

    Background: Recurrence in glioblastoma lacks a standardized treatment, prompting an exploration of re-irradiation’s efficacy. Methods: A comprehensive systematic review from January 2005 to May 2023 assessed the role of MRI sequences in recurrent glioblastoma re-irradiation. The search criteria, employing MeSH terms, targeted English-language, peer-reviewed articles. The inclusion criteria comprised both retrospective and prospective studies, excluding certain types and populations for specificity. The PICO methodology guided data extraction, and the statistical analysis employed Chi-squared tests via MedCalc v22.009. Results: Out of the 355 identified studies, 81 met the criteria, involving 3280 patients across 65 retrospective and 16 prospective studies. The key findings indicate diverse treatment modalities, with linac-based photons predominating. The median age at re-irradiation was 54 years, and the median time interval between radiation courses was 15.5 months. Contrast-enhanced T1-weighted sequences were favored for target delineation, with PET-imaging used in fewer studies. Re-irradiation was generally well tolerated (median G3 adverse events: 3.5%). The clinical outcomes varied, with a median 1-year local control rate of 61% and a median overall survival of 11 months. No significant differences were noted in the G3 toxicity and clinical outcomes based on the MRI sequence preference or PET-based delineation. Conclusions: In the setting of recurrent glioblastoma, contrast-enhanced T1-weighted sequences were preferred for target delineation, allowing clinicians to deliver a safe and effective therapeutic option; amino acid PET imaging may represent a useful device to discriminate radionecrosis from recurrent disease. Future investigations, including the ongoing GLIAA, NOA-10, ARO 2013/1 trial, will aim to refine approaches and standardize methodologies for improved outcomes in recurrent glioblastoma re-irradiation.


  • Open Access

    Fractionated Stereotactic Radiotherapy with Helical Tomotherapy for Brain Metastases: A Mono-Institutional Experience

    by Francesco Cuccia, Salvatore D’alessandro, Giuseppe Carruba, Vanessa Figlia, Antonio Spera, Daniela Cespuglio, Gianluca Mortellaro, Giuseppina Iacoviello, Antonio Lo Casto, Giovanni Tringali, et al.

    Background: The present study reports on the outcomes of our mono-institutional experience of Helical Tomotherapy (HT)-based SRT for brain metastases. The use of this linac is less frequently reported for this kind of treatment. Methods: This retrospective study displays a series of patients treated with HT-SRT. The eligibility of using SRT for brain metastases was defined by a Karnofsky performance status of >70, a life expectancy of >6 months, and controlled extra-cranial disease; no SRT was allowed in the case of a number of brain metastases larger than 10. All the cases were discussed by a multidisciplinary board. Toxicity assessments were performed based on CTCAE v5.0. Survival endpoints were assessed using the Kaplan–Meier method, and univariate and multivariate analyses were carried out to identify any potential predictive factor for an improved outcome. Results: Sixty-four lesions in 37 patients were treated using HT-SRT with a median total dose of 30 Gy in five fractions. The median follow-up was 7 months, and the 1- and 2-year LC rates were both 92.5%. The IPFS rates were and 56.75% and 51.35%. The OS rates were 54% and 40%. The UA showed better IPFS rates significantly related to male sex (p = 0.049), a BED12 of ≥42 Gy (p = 0.006), and controlled extracranial disease (p = 0.03); in the MA, a favorable trend towards LC (p = 0.11) and higher BED (p = 0.11) schedules maintained a correlation with improved IPFS rates, although statistical significance was not reached. Conclusions: HT-based SRT for brain metastases showed safety and efficacy in our monoinstiutional experience. Higher RT doses showed statistical significance for improved outcomes of LC and OS.


  • Open Access

    Branch vessel occlusion in aneurysm treatment with flow diverter stent

    by Sophia Hohenstatt, Antonio Arrichiello, Giorgio Conte, Giuseppe Craparo, Ferdinando Caranci, Alessio Angileri, Daniel Levi, Gianpaolo Carrafiello, Aldo Paolucci

    Flow diverter placement for treatment of intracranial aneurysms gained growing consensus in the past years. A major concern among professionals is the side branch coverage which leads in some cases to vessel occlusion. However, the lost vessel patency only infrequently is accompanied by a new onset of neurological deficits secondary to ischaemic lesions. A retrospective analysis of all patients treated with flow diversion at our hospital was aimed to better understand this phenomenon in order to formulate a hypothesis about the causes. We concluded that vessel occlusion occurs due to a reduced blood pressure gradient in those vessels with a strong collateral or anastomotic vascularization that refurnishes the same distal vascular territories. Indeed, we detected no new brain infarction since blood flow was always guaranteed.


  • Open Access

    Flow diverting devices in acute ruptured blood blister aneurysms: a three centric retrospective study

    by Francesca Incandela, Giuseppe Craparo, Sergio Abrignani, Agostino Tessitore, Antonio Pitrone, Ferdinando Caranci, Antonio Arrichiello, Aldo Paolucci

    Background: Blood blister aneurysms (BBAs) are a rare tiny subset of intracranial aneurysms, located at the nonbranching site of an artery, representing a therapeutic challenge from both surgical and endovascular approach. Flow-diverting efficacy, by preserving flow through the parent artery, was approved for its use in unruptured cerebral aneurysms, but no consensus was reached on its use for BBAs ruptured in the acute setting. We report a multicenter experience of use of flow diversion in acute setting of ruptured BBA, to analyze the safety and efficacy of these devices. Methods: We performed a retrospective study of 6 consecutive intracranial BBAs treated with flow diverter devices (FDD) between 2018 and 2020 at 3 italian institutions. Materials, therapy used, complications, clinical and radiographic outcomes were reviewed. Results: We used different FDD, in all cases immediate change in contrast opacification at the end of the procedure was reported. Intraprocedural IIb/IIIa inhibitor agent was the major antiplatelet protocol administered. Any complications occurred. All patients showed complete BBA obliteration at 3 months follow-up. 5/6 patients achieved good clinical outcome (0–2 mRS) at 3 months, all of which were presented with low grade SAH (Hunt Hess I–III) and a lower Fisher grade. Conclusion: Our data support this endovascular technique as a safe and effective therapeutic modality for this pathology in the acute setting.